Serum dopamine-beta-hydroxylase activity: Clinical applications in child psychiatry | SpringerLink

Belmaker, R. H., Hattab, J., & Ebstein, R. P. Plasma dopamine-β-hydroxylase in childhood psychosis.Journal of Autism and Childhood Schizophrenia, 1978,8, 293–298.

Christianson, N. J. Plasma noradrenaline and adrenaline in patients with thyrotoxicosis and myxodema.Clinical Science and Molecular Medicine, 1973,45, 163–171.

Cohen, D. J., Shaywitz, B. A., Johnson, W. T., & Bowers, M. B., Jr. Biogenic amines in autistic and atypical children.Archives of General Psychiatry 1974,31, 845–853.

Cohen, D. J., & Young, J. G. Neurochemistry and child psychiatry.Journal of the American Academy of Child Psychiatry, 1977,16, 353–411.

Coleman, M., Campbell, M., Freedman, L. S., Roffman, M., Ebstein, R. P., & Goldstein, M. Serum dopamine-beta-hydroxylase levels in Down’s syndrome.Clinical Genetics, 1974,5, 312–315.

Ebstein, R. P., Freedman, L. S., Lieberman, A., Park, D. H., Pasternack, B., Goldstein, M., & Coleman, M. A familial study of serum dopamine-β-hydroxylase levels in torsion dystonia.Neurology, 1974,24, 684–687.

Freedman, L. S., Ohuchi, T., Goldstein, M., Axelrod, F., Fish, I., & Dancis, J. Changes in human serum dopamine-β-hydroxylase activity with age.Nature, 1972,236, 310–311.

Goldstein, D. J., & Cubeddu, L. Dopamine-beta-hydroxylase activity in human cerebrospinal fluid.Journal of Neurochemistry, 1976,26, 193–195.

Goldstein, M. Dopamine-beta-hydroxylase and endogenous total 5-hydroxyindole levels in autistic patients and controls. In M. Coleman (Ed.),The autistic syndromes. New York: North-Holland, 1976. Pp. 57–58.

Goldstein, M., Freedman, L. S., Ebstein, R. P., Park, D. H., & Kashimoto, T. Human serum dopamine-beta-hydroxylase: Relationship to sympathetic activity and physiological and pathological states. In E. Usdin (Ed.),Neuropsychopharmacology of monoamines and their regulatory systems. New York: Raven Press, 1974.

Kanter, W., Wooten, G. F., & Eldridge, R. Dopamine-β-hydroxylase and the torsion dysstonias. In R. Eldrige (Ed.),Advances in neurology (Vol. 14). New York: Raven Press, 1976. Pp. 303–305.

Klawans, H. L., & Shenker, D. M. Observations on the dopaminergic nature of hyperthyroid chorea.Journal of Neural Transmission, 1972,33, 73–81.

Laduron, P. Scope and limitation in dopamine-beta-hydroxylase measurement.Biochemistry and Pharmacology, 1975,24, 557–562.

Lake, C. R., Ziegler, M. G., & Murphy, D. L. Increased norepinephrine levels and decreased dopamine-β-hydroxylase activity in primary autism.Archives of General Psychiatry, 1977,34, 553–556.

Lamprecht, F., Williams, R. B., & Kopin, I. J. Serum dopamine-beta-hydroxylase during development of immobilization-induced hypertension.Endocrinology, 1973,92, 953–956.

Lamprecht, F., Wyatt, R. J., Belmaker, R., Murphy, D. L., & Pollin, W. Plasma dopamine-beta-hydroxylase in identical twins discordant for schizophrenia. In E. Usdin & S. H. Snyder (Eds.),Frontiers in catecholamine research. New York: Pergamon Press, 1973.

Leckman, J. F., Cohen, D. J., Shaywitz, B. A., Caparulo, B. K., Heninger, G. R., & Bowers, M. B., Jr. Homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) in the cerebrospinal fluid of childhood and adult psychiatric patients: A developmental perspective.Archives of General Psychiatry, 1980, in press.

Meltzer, H. Y., Cho, H. W., Carroll, B. J., & Russo, P. Serum dopamine-β-hydroxylase activity in the affective psychoses and schizophrenia.Archives of General Psychiatry, 1976,33, 585–591.

Nagatsu, T., & Udenfriend, S. Photometric assay of dopamine-β-hydroxylase activity in human blood.Clinical Chemistry, 1972,18, 980–983.

Nishizawa, Y., Hamada, N., Fujii, S., Morii, H., Okuda, K., & Wada, M. Serum dopamine-β-hydroxylase activity in thyroid disorders.Journal of Clinical Endocrinology and Metabolism, 1974,39, 599–601.

Noth, R. H., & Mulrow, P. J. Serum dopamine-beta-hydroxylase as an index of sympathetic nervous system activity in man.Circulation Research, 1976,38, 2–5.

Noth, R. H., & Spaulding, S. W. Decreased serum dopamine-β-hydroxylase in hyperthyroidism.Journal of Clinical Endocrinology and Metabolism, 1974,39, 614–617.

Planz, G., & Palm, D. Acute enchancement of dopamine-β-hydroxylase activity in human plasma after maximum work load.European Journal of Clinical Pharmacology, 1973,5, 255–258.

Reid, J. L., & Kopin, I. J. Significance of plasma dopamine-beta-hydroxylase activity as an index of sympathetic neuronal function.Proceedings of the National Academy of Sciences, USA, 1974,71, 4392–4394.

Ross, S. B., Wetterberg, L., & Myrhed, M. Genetic control of plasma dopamine-β-hydroxylase.Life Sciences, 1973,12, 529–532.

Rush, R. A., & Geffen, L. B. Radioimmunoassay and clearance of circulatory dopamine-β-hydroxylase.Circulation Research, 1972,31, 444–447.

Schanberg, S. M., & Kirshner, N. Serum dopamine-β-hydroxylase as an indicator of sympathetic activity and primary hypertension.Biochemical Pharmacology, 1976,25, 617–621.

Seligson, H., & Seligson, D. Measurement of thyroxine by competitive protein binding.Clinica Chimica Acta, 1972,38, 199–204.

Stoffer, S. S., Jiang, N. S., Gorman, C. A., & Pikler, G. M. Plasma catecholamines in hypothyroidism and hyperthyroidism.Journal of Clinical Endocrinology and Metabolism, 1973,36, 587–589.

The Task Force on Nomenclature and Statistics of the American Psychiatric Association.Diagnostic and statistical manual of mental disorders (3rd ed.). New York, authors, 1978.

Weinshilboum, R., & Axelrod, J. Serum dopamine-beta-hydroxylase activity.Circulation-Research, 1971,28, 307–315. (a)

Weinshilboum, R., & Axelrod, J. Serum dopamine-beta-hydroxylase: Decrease after chemical sympathectomy.Science, 1971,197, 931–934. (b)

Weinshilboum, R. M., Dunnette, J. H., Raymond, F. A., & Schrott, H. G. Genetic control of human serum dopamine-β-hydroxylase. In E. Usdin, R. Kvetnansky, & I. J. Kopin (Eds.),Catecholamines and stress. New York: Pergamon Press, 1976. Pp. 293–303.

Weinshilboum, R. M., Nguyen, B. T., Johnson, D. G., Kopin, I. J., & Axelrod, J. Proportional release of norepinephrine and dopamine-β-hydroxylase from sympathetic nerves.Science, 1971,174, 1349–1351.

Weinshilboum, R. M., Raymond, F. A., Elveback, L. R., & Weidman, W. H. Serum dopamine-beta-hydroxylase activity: Sibling-sibling correlation.Science, 1973,181, 943–945.

Wooten, F. G., & Cardon, P. V. Plasma dopamine-beta-hydroxylase activity: Elevation in man during cold pressor test and exercise.Archives of Neurology, 1973,28, 103–106.

Wooten, G. F., Eidridge, R., Axelrod, J., & Stern, R. S. Elevated plasma dopamine-β-hydroxylase activity in autosomal dominant torsion dystonia.New England Journal of Medicine, 1973,28, 284–287.

Wyatt, R. J., Potkin, S. G., & Murphy, D. L. Platelet monoamine oxidase activity in schizophrenia: A review of the data.American Journal of Psychiatry, 1979,136, 377–385.

Young, J. G., & Cohen, D. J. The molecular biology of development. In J. Nospitz (Ed.),Basic handbook of child psychiatry (Vol. 1). New York: Basic Books, 1979. Pp. 22–62.

Young, J. G., Cohen, D. J., Brown, S.-L., & Caparulo, B. K. Decreased urinary free catecholamines in childhood autism.Journal of the American Academy of Child Psychiatry, 1978,17, 671–678.

Young, J. G., Cohen, D. J., Caparulo, B. K., Brown, S.-L., & Maas, J. W. Decreased 24-hour urinary MHPG in childhood autism.American Journal of Psychiatry, 1979,236, 1055–1057.

Young, J. G., Cohen, D. J., Waldo, M. C., Feiz, R., & Roth, J. A. Platelet monoamine oxidase activity in children and adolescents with psychiatric disorders.Schizophrenia Bulletin, 1980, in press.

Young, J. G., Kyprie, R. M., & Cohen, D. J. Studies of catecholamine-thyroid hormone interactions. III. Lack of association between serum dopamine-beta-hydroxylase activity and thyroxine in euthyroid subjects.Schizophrenia Bulletin, 1980, in press.

Ziegler, M. G., Lake, C. R., Eldridge, R., & Kopin, I. J. Plasma norepinephrine and dopamine-β-hydroxylase in dystonia. In R. Eldridge (Ed.),Advances in neurology (Vol. 14). New York: Raven Press, 1976. Pp. 307–315.